These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17067268)

  • 21. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
    Quiñones-Mateu ME; Albright JL; Mas A; Soriano V; Arts EJ
    J Virol; 1998 Nov; 72(11):9002-15. PubMed ID: 9765445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects.
    Monno L; Scudeller L; Brindicci G; Saracino A; Punzi G; Chirianni A; Lagioia A; Ladisa N; Lo Caputo S; Angarano G
    Antiviral Res; 2009 Aug; 83(2):118-26. PubMed ID: 19549585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy.
    Brandin E; Lindborg L; Gyllensten K; Broström C; Hagberg L; Gisslen M; Tuvesson B; Blaxhult A; Albert J
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):543-50. PubMed ID: 12908931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference.
    Han X; Zhang M; Dai D; Wang Y; Zhang Z; Liu J; Geng W; Jiang Y; Takebe Y; Shang H
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):357-64. PubMed ID: 17411368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
    Kantor R; Katzenstein D
    AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users.
    Thomson MM; Delgado E; Manjón N; Ocampo A; Villahermosa ML; Mariño A; Herrero I; Cuevas MT; Vázquez-de Parga E; Pérez-Alvarez L; Medrano L; Taboada JA; Nájera R;
    AIDS; 2001 Mar; 15(4):509-16. PubMed ID: 11242148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.
    Rhee SY; Kantor R; Katzenstein DA; Camacho R; Morris L; Sirivichayakul S; Jorgensen L; Brigido LF; Schapiro JM; Shafer RW;
    AIDS; 2006 Mar; 20(5):643-51. PubMed ID: 16514293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.
    Alexander CS; Dong W; Chan K; Jahnke N; O'Shaughnessy MV; Mo T; Piaseczny MA; Montaner JS; Harrigan PR
    AIDS; 2001 Mar; 15(5):601-7. PubMed ID: 11316997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission patterns of HIV-subtypes A/AE versus B: inferring risk-behavior trends and treatment-efficacy limitations from viral genotypic data obtained prior to and during antiretroviral therapy.
    Avidor B; Turner D; Mor Z; Chalom S; Riesenberg K; Shahar E; Pollack S; Elbirt D; Sthoeger Z; Maayan S; Olshtain-Pops K; Averbuch D; Chowers M; Istomin V; Anis E; Mendelson E; Ram D; Levy I; Grossman Z
    PLoS One; 2013; 8(3):e57789. PubMed ID: 23469241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia.
    Tee KK; Kamarulzaman A; Ng KP
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):121-4. PubMed ID: 16478392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.
    Mezei M; Ay E; Koroknai A; Tóth R; Balázs A; Bakos A; Gyori Z; Bánáti F; Marschalkó M; Kárpáti S; Minárovits J
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1243-7. PubMed ID: 21453184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New subtypes and genetic recombination in HIV type 1-infecting patients with highly active antiretroviral therapy in Peru (2008-2010).
    Yabar CA; Acuña M; Gazzo C; Salinas G; Cárdenas F; Valverde A; Romero S
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1712-22. PubMed ID: 22559065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic prediction of resistant mutation in HIV-1 pol gene towards the antiretroviral drugs.
    Kumar A; Jadhav C
    Int J Bioinform Res Appl; 2011; 7(1):15-23. PubMed ID: 21441094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi.
    Petch LA; Hoffman IF; Jere CS; Kazembe PN; Martinson FE; Chilongozi D; Fiscus SA; Cohen MS
    AIDS Res Hum Retroviruses; 2005 Sep; 21(9):799-805. PubMed ID: 16218804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.
    Kantor R; Zijenah LS; Shafer RW; Mutetwa S; Johnston E; Lloyd R; von Lieven A; Israelski D; Katzenstein DA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1407-13. PubMed ID: 12512512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
    Varella RB; Ferreira SB; de Castro MB; Zalis MG; Tavares MD
    J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
    Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients.
    Birk M; Sönnerborg A
    AIDS; 1998 Dec; 12(18):2369-75. PubMed ID: 9875574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.